Page 9 - Josh Bartch News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Psilocybin Patent Race Is On It feels like these companies are casting a wide net, but it makes sense to file at the beginning of this mushroom mania. Mar 06, 2021 | 12:30 PM EST It seems that a week doesn't go by without a psychedelic company saying it has filed for a patent of some sort. This process can be confusing as the first assumption is that these companies are trying to patent a natural product. It isn't difficult to see how this misunderstanding happens. The headlines shout psychedelic company! Psilocybin! Patent! That, however, isn't exactly what is happening. Truth Be...

Mydecine Innovations Group, Inc., is pleased to announce that its subsidiary Mindleap Health a digital health platform and the world’s-first telemedicine application purpose-built for the psychedelic medicine industry, has filed a provisional patent for its technology platform in both The United States Patent and Trademark Office and the Canadian Intellectual Property Office. “As our company continues to innovate … Mydecine Innovations Group, Inc., ( CSE:MYCO ) ( OTC:MYCOF ) ( FSE:0NFA ) (“Mydecine” or the “Company”) is pleased to announce that its subsidiary Mindleap Health (�...

Magic mushroom therapy could help treat PTSD in Canadian military vets "If we can bring something new to offer our veterans that have basically sacrificed body and mind for our countries, that's really our goal." Author of the article: Sam Riches Publishing date: Feb 16, 2021  •  February 16, 2021  •  5 minute read According to Veterans Affairs Canada, it is estimated that up to 10 per cent of war zone veterans — including war-service veterans and peacekeeping forces — will experience PTSD. Photo by Wikimedia Commons Article content This story first appeared in Weekend Di...

Mydecine Innovations Group Appoints Josephine Wu to Board of Directors Mydecine Innovations Group an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, announced the appointment of Josephine Wu, Founder and CIO at Aionious Management, Ltd., to the Company’s Board of Directors. Josh Bartch, Chairman and CEO of Mydecine, stated, “The Board of Directors welcomes Ms. Josephine Wu … Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), a...

Mydecine Innovations Group Receives Conditional Approval to List on NEO Exchange Mydecine Innovations Group an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, announced today that it has received Conditional Approval to migrate and uplist its common shares with the NEO Exchange . Final approval is subject to the Company fulfilling all of NEO’s listing requirements. With the impending … Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Compa...